Biblio

Export 876 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Humans  [Clear All Filters]
2024
J. Paul Ross, Post, S. G., and Scheinfeld, L., “Lucidity in the Deeply Forgetful: A Scoping Review.”, J Alzheimers Dis, vol. 98, no. 1, pp. 3-11, 2024.
C. M. Keith, Haut, M. W., Teixeira, C. Vieira Lig, Mehta, R. I., Phelps, H., Ward, M., Miller, M., R Navia, O., Coleman, M. M., Marano, G., Wang, X., Pockl, S., Rajabalee, N., Scarisbrick, D. M., McCuddy, W. T., D'Haese, P. - F., Rezai, A., and Wilhelmsen, K., “Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment.”, J Alzheimers Dis, vol. 102, no. 3, pp. 778-791, 2024.
M. Sultana, Camicioli, R., Dixon, R. A., Whitehead, S., Pieruccini-Faria, F., Petrotchenko, E., Speechley, M., Borchers, C. H., and Montero-Odasso, M., “A Metabolomics Analysis of a Novel Phenotype of Older Adults at Higher Risk of Dementia.”, J Alzheimers Dis, vol. 99, no. s2, pp. S317-S325, 2024.
Y. Li, Chen, X., Zhou, M., Feng, S., Peng, X., and Wang, Y., “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
R. Yan, Wang, W., Yang, W., Huang, M., and Xu, W., “Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 99, no. s2, pp. S299-S315, 2024.
E. Rossi, Marrosu, F., and Saba, L., “Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 98, no. 1, pp. 33-51, 2024.
Y. Cabrera-León, Báez, P. García, Fernández-López, P., and Suárez-Araujo, C. Paz, “Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.”, J Alzheimers Dis, vol. 98, no. 3, pp. 793-823, 2024.
Z. Shen, Yang, X., Lan, Y., and Chen, G., “The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 741-754, 2024.
O. Almkvist, Larsson, M., and Graff, C., “Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
P. Du, Zhang, X., Lian, X., Holscher, C., and Xue, G., “O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1051-1068, 2024.
A. M. R. McLaren and Kawaja, M. D., “Olfactory Dysfunction and Alzheimer's Disease: A Review.”, J Alzheimers Dis, vol. 99, no. 3, pp. 811-827, 2024.
R. A. Mace, Lyons, C., Cohen, J. E., Ritchie, C., Bartels, S., Okereke, O. I., Hoeppner, B. B., Brewer, J. A., and Vranceanu, A. - M., “Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.”, J Alzheimers Dis, vol. 100, no. 4, pp. 1237-1259, 2024.
J. Maters, van der Steen, J. T., de Vugt, M. E., Bakker, C., and Koopmans, R. T. C. M., “Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.”, J Alzheimers Dis, vol. 97, no. 2, pp. 573-586, 2024.
X. Morató, Tartari, J. Pablo, Pytel, V., and Boada, M., “Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. s1, pp. S285-S298, 2024.
B. Zeng, Tang, C., Wang, J., Yang, Q., Ren, Q., and Liu, X., “Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1173-1186, 2024.
X. Huang, Wang, J., Zhang, S., Zhao, X., An, R., Lan, Y., Yi, M., and Wan, Q., “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
J. M. Chandler, Ye, W., Mi, X., Doty, E. G., and Johnston, J. A., “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
L. Zuo, Hu, Y., Dong, Y. H., Seet, R. Cs, Li, Z., Wang, Y., and Zhao, X., “Pre-existing dementia is associated with 2-3 folds risk for in-hospital mortality and complications after intracerebral hemorrhage stroke.”, J Alzheimers Dis, vol. 102, no. 2, pp. 338-346, 2024.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E., “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
H. Stevens Smith, Robinson, J. O., Levchenko, A., Pereira, S., Pascual, B., Bradbury, K., Arbones, V., Fong, J., Shulman, J. M., McGuire, A. L., and Masdeu, J., “Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1261-1274, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
G. Alva, Cubała, W. J., Berrio, A., Coate, B., Abler, V., and Pathak, S., “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.

Pages